Johan Rockberg PhD

Assistant Professor Johan Rockberg has an undergraduate training as Chemical Engineer with focus on biotechnology and bioinformatics from KTH and the University of Sydney. He defended his doctoral thesis entitled “Methods for generation and characterization of mono-specific antibodies” at KTH in 2008 . Dr Rockberg has been a group leader since 2009 focusing on development of antibodies and since 2013 focusing on methods for strain-development and screening in CHO cells. Apart from this, Dr. Rockberg is a co-founder of Abclon inc. (Korea) and Atlas Therapeutics AB and has held positions as Senior Researcher and Director of Biosynergy at Alligator Bioscience 2013-2014.